EcoDrugPlus

Thromboxane A Synthase 1 (Platelet)

Ensembl ID : ENSNBRG00000015366
Gene Symbol: TBXAS1
1 Cross references
207 Possible Orthologues:

Thromboxane A2 Receptor-Like

Ensembl ID : ENSNBRG00000002408
Gene Symbol: LOC102795765
3 Cross references
192 Possible Orthologues:

Thymidine Phosphorylase

Ensembl ID : ENSNBRG00000014459
Gene Symbol: TYMP
4 Cross references
172 Possible Orthologues:

Thymidylate Synthase-Like

Ensembl ID : ENSNBRG00000014804
Gene Symbol: LOC102797459
3 Cross references
223 Possible Orthologues:

Thyroid Hormone Receptor Beta-Like

Ensembl ID : ENSNBRG00000006722
Gene Symbol: LOC102787326
3 Cross references
388 Possible Orthologues:

Thyrotropin Releasing Hormone Receptor

Ensembl ID : ENSNBRG00000008391
Gene Symbol: TRHR
3 Cross references
201 Possible Orthologues:

Thyrotropin-Releasing Hormone Receptor-Like

Ensembl ID : ENSNBRG00000016621
Gene Symbol: LOC102793365
3 Cross references
193 Possible Orthologues:

Tissue Factor-Like

Ensembl ID : ENSNBRG00000015346
Gene Symbol: LOC102797893
3 Cross references
199 Possible Orthologues:

Toll Like Receptor 7

Ensembl ID : ENSNBRG00000008807
Gene Symbol: TLR7
3 Cross references
197 Possible Orthologues:

Toll-Like Receptor 2-Like

Ensembl ID : ENSNBRG00000000495
Gene Symbol: LOC102797018
3 Cross references
213 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSNBRG00000006846
Gene Symbol: TAAR1
3 Cross references
428 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSNBRG00000013018
Gene Symbol: TAAR1
1 Cross references
347 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).